Recent evidence suggests that a novel serotonin receptor 5-HT7 localized in
the hypothalamus downregulates in response to treatment with the antidepre
ssant fluoxetine (Sleight et al. 1995). This receptor has also been implica
ted in the regulation of circadian rhythms (Lovenberg et al. 1993). Here, w
e show that several agents administered in a profile consistent with activi
ty at the 5-HT7 receptor produce significant functional Fos immunoreactivit
y in the suprachiasmatic nucleus (SCN), an effect reduced upon chronic expo
sure. Furthermore, binding studies demonstrate that chronic administration
of Fos-inducing agents produces a neuroadaptive downregulation of the 5-HT7
receptor in the hypothalamus. The current studies extend the previous obse
rvations to include several pharmacologically distinct antidepressants. In
addition, these studies provide further evidence to support the role of the
5-HT7 receptor in the mechanism of anti-depressant action and in the regul
ation of circadian rhythms controlled by the SCN. (C) 1999 American College
of Neuropsychopharmacology. Published by Elsevier Science Inc.